Atherosclerosis

Researchers Explore Nanofibers to Target, Treat Atherosclerosis

Researchers Explore Nanofibers to Target, Treat Atherosclerosis

Study showed 11% and 9% plaque reduction in treated male and female mice compared with controls.

Reforms Suggested for Improving Medical Nutrition Education

Reforms Suggested for Improving Medical Nutrition Education

Enhancing physician training will increase engagement in diet counseling for patients with ASCVD.

Psoriasis Treatment Ixekizumab Safe for Cardiovascular Health

Psoriasis Treatment Ixekizumab Safe for Cardiovascular Health

Biologic therapies for psoriasis may have an impact on cardiovascular parameters, potentially resulting in the occurrence of major adverse cardiovascular events.

High Financial Burden for Families of Patients With ASCVD

High Financial Burden for Families of Patients With ASCVD

High burden of expenses were seen for 1 in 4 low-income families with a member with atherosclerotic cardiovascular disease.

Eating Veggies Found to Protect Against Atherosclerosis in Women

Eating Veggies Found to Protect Against Atherosclerosis in Women

Broccoli, cauliflower, cabbage, and brussels sprouts were most beneficial in terms of preventing subclinical atherosclerosis.

High-Risk Coronary Plaque Detection by CTA in Chest Pain May Predict MACE

High-Risk Coronary Plaque Detection by CTA in Chest Pain May Predict MACE

By

Patients with stable chest pain who have high-risk plaque as identified by coronary computed tomographic angiography may have a higher risk for MACE.

Diabetes Independently Associated With Coronary Artery Calcification

Diabetes Independently Associated With Coronary Artery Calcification

Diabetes and prediabetes duration are both independently associated with the presence of coronary artery calcified plaque.

Wider Statin Use May Prevent More Atherosclerotic CVD Events

Wider Statin Use May Prevent More Atherosclerotic CVD Events

Guidelines that recommend statins for more people for primary prevention of atherosclerosis are likely to prevent more ASCVD events than guidelines that recommend fewer people take statins.

LDL Cholesterol Independently Associated With Subclinical Atherosclerosis

LDL Cholesterol Independently Associated With Subclinical Atherosclerosis

By

In an analysis of the PESA study, nearly 50% of patients without cardiovascular risk factors had subclinical atherosclerosis.

Carotid Plaque, Vascular Disease Event Risk Increase With HIV

Carotid Plaque, Vascular Disease Event Risk Increase With HIV

By

Findings show that HIV status was associated with an increased rate of incidental carotid plaque, noncalcified plaque, and high-risk plaque.

Simpler Tool Effectively Evaluates Subclinical Atherosclerosis Risk

Simpler Tool Effectively Evaluates Subclinical Atherosclerosis Risk

The ideal cardiovascular health score and the Fuster-BEWAT score are similar in their ability to predict subclinical atherosclerosis.

Atherosclerotic CVD Benefits From Statins

Atherosclerotic CVD Benefits From Statins

For patients who have experienced an atherosclerotic cardiovascular disease event, receipt of statins, especially high-intensity statins, is associated with reduced risk of major adverse cardiac events.

Canakinumab May Lower Lung Cancer Incidence in Patients With Atherosclerosis

Canakinumab May Lower Lung Cancer Incidence in Patients With Atherosclerosis

By

Anti-inflammatory therapy with canakinumab may result in a significantly lower incidence of lung cancer and lung cancer mortality.

Intracranial Atherosclerotic Plaque Prevalence May Vary by Race

Intracranial Atherosclerotic Plaque Prevalence May Vary by Race

Black men have increased prevalence and frequency of multiple intracranial atherosclerotic plaques.

Effect of Exercise on Coronary Artery Calcification

Effect of Exercise on Coronary Artery Calcification

White males who participate in 3 times the recommended physical activity over many years have higher odds of developing coronary subclinical atherosclerosis.

Reduced Forced Vital Capacity May Be Useful for Risk Assessment of Arterial Stiffness

Reduced Forced Vital Capacity May Be Useful for Risk Assessment of Arterial Stiffness

By

Restrictive spirometry pattern and reduced forced vital capacity level are associated with increased risk of arterial stiffness.

Sudden Death Most Common Cause of CV Death in Diabetes and Atherosclerotic CVD

Sudden Death Most Common Cause of CV Death in Diabetes and Atherosclerotic CVD

Sudden death is the most common category of cardiovascular mortality among patients with type 2 diabetes and atherosclerotic CVD.

Coronary Artery Calcium Useful in Predicting Cardiovascular Risk in COPD

Coronary Artery Calcium Useful in Predicting Cardiovascular Risk in COPD

By

Coronary artery calcium may be the best noninvasive risk marker for predicting a major cardiovascular event in patients with COPD.

Factors Associated With Accelerated Atherosclerosis in Spondyloarthritis Without Overt CVD

Factors Associated With Accelerated Atherosclerosis in Spondyloarthritis Without Overt CVD

By

Certain factors have been associated with accelerated atherosclerosis in spondyloarthritis without overt cardiovascular disease.

Atherosclerosis Risk Increased When Skipping Breakfast

Atherosclerosis Risk Increased When Skipping Breakfast

Habitual skipping of breakfast is associated with increased likelihood of atherosclerosis independent of traditional and dietary cardiovascular risk factors.

Anacetrapib Reduces Major Coronary Events When Added to Intensive Statin Therapy

Anacetrapib Reduces Major Coronary Events When Added to Intensive Statin Therapy

Lower incidence of major coronary events for patients with atherosclerotic vascular disease receiving intensive statins is linked with use of anacetrapib.

PCSK9 Inhibitor Evolocumab Continues to Lack Cost-Effectiveness

PCSK9 Inhibitor Evolocumab Continues to Lack Cost-Effectiveness

Findings for addition of evolocumab to standard tx in atherosclerotic cardiovascular disease

Greater CV Benefit With Rivaroxaban Plus Aspirin vs Monotherapy in Stable ASCVD

Greater CV Benefit With Rivaroxaban Plus Aspirin vs Monotherapy in Stable ASCVD

By

Despite more major bleeding events, rivaroxaban plus aspirin therapy had a greater cardiovascular benefit in patients with stable atherosclerotic vascular disease vs monotherapy.

Role of Race and Ethnicity in Cardiovascular Health

Role of Race and Ethnicity in Cardiovascular Health

By

Experts weigh in on how to improve racial and ethnic disparities in cardiovascular health.

Measuring Visceral Adipose Tissue With DXA to Predict Atherosclerotic CVD

Measuring Visceral Adipose Tissue With DXA to Predict Atherosclerotic CVD

By

Fourteen percent of study participants experienced incident athersclerotic cardiovascular disease events.

Gray Hair Predictive of Coronary Artery Disease in Men

Gray Hair Predictive of Coronary Artery Disease in Men

By

Hair whitening score, hypertension, and dyslipidemia were all independent predictors of atherosclerotic coronary artery disease.

FOURIER Trial Data Questions: Are PCSK9 Inhibitors The Right Choice?

FOURIER Trial Data Questions: Are PCSK9 Inhibitors The Right Choice?

Results of the FOURIER trial, presented at the 2017 ACC Scientific Sessions, raise questions about the efficacy of PCSK9 inhibitors as long-term therapy for patients with atherosclerotic CVD.

Patient-Clinician Communication Key in Managing Heart Disease Treatment

Patient-Clinician Communication Key in Managing Heart Disease Treatment

Two studies examined the positive outcomes of clear patient-clinician communication on management and treatment of heart disease.

Novel Multimodality Testing Strategy Improves CVD Risk Assessment

Novel Multimodality Testing Strategy Improves CVD Risk Assessment

A mutlimodal strategy combines 5 separate tests to significantly improve CVD and ASVCD risk assessment.

Statin Eligibility Requirements In African Americans With Atherosclerosis

Statin Eligibility Requirements In African Americans With Atherosclerosis

According to ACC/AHA Guidelines presented at ACC 2017, targeted imaging should be used to personalize statin recommendation programs.

Sign Up for Free e-Newsletters